A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia

Novo Nordisk A/S1,832 enrolled

Overview

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Asia. Further perceptions and practices of physicians and subjects about diabetes management in Asia will be evaluated.

Study Type

OBSERVATIONAL

Enrollment

1,832

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions

No treatment givenOTHER

No treatment is given

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetic patients registered in the particular centre for more than 12 months. * Patients should have visited the centre at least once in the last 3-6 months before the initial study visit. * Patients willing to sign informed consent form. Exclusion Criteria: * Repetition of any patient as patients should not be included twice for any reason. * Unwilling to participate or unable to comply with protocol requirements.

Locations (1)

Unnamed facility

Jakarta, Indonesia

Outcomes

Primary Outcomes

Mean age of onset of either type 1 or type 2 diabetes mellitus

Time frame: study visit

Mean duration of treatment of type 2 diabetes mellitus.

Time frame: study visit

Percentage of patients on either insulin therapy or OAD (oral anti-diabetic drug) therapy.

Time frame: study visit

Mean duration of diabetes in type 1 and type 2 diabetes patients respectively.

Time frame: study visit

Mean FPG (fasting plasma glucose),PPG (post prandial glucose) and HbA1c of diabetic patients.

Time frame: study visit

Percentage of diabetic patients with HbA1c target below or equal to 7.0%.

Time frame: study visit

Percentage of diabetic patients with HbA1c target below or equal to 6.5%.

Time frame: study visit

Percentage of diabetic patients having dyslipidemia and hypertension

Time frame: study visit

Percentage of diabetic patients having cardiovascular complications

Time frame: study visit

Percentage of diabetic patients having peripheral vascular disease

Time frame: study visit

Percentage of diabetic patients having diabetic nephropathy

Time frame: study visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Secondary Outcomes

Patients' perception will be analysed through Patient questionnaire measuring:Psychological well-being, Quality of life and Patients' compliant to treatment

Time frame: study visit

Physician questionnaire measuring awareness about:HbA1c test and its goal, Anti-diabetic treatment and Barriers towards optimum diabetes control

Time frame: study visit

Duration of diabetes associated with highest number of diabetic complications

Time frame: study visit

Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy)

Time frame: study visit